BUZZ-Australia's Zelira Therapeutics surges on $33 million funding for drug trial
Reuters
Jan 16
BUZZ-Australia's Zelira <a href="https://laohu8.com/S/LENZ">Therapeutics</a> surges on $33 million funding for drug trial
** Shares of Zelira Therapeutics ZLD.AX rise as much as 151.4% to A$0.905, hitting their highest level since Nov. 15, 2024
** Stock marks its biggest intraday pct gain since May 31, 2023
** Biopharma co inks deal with TGC Biotechnology fund to raise $33 million
** Says funding for its HOPE1 SPV, financial structure created by co to fund development & clinical trials for its cannabinoid drug HOPE® 1
** Stock has gained 125% so far this week, up nearly 100% YTD
(Reporting by Rajasik Mukherjee in Bengaluru)
((Rajasik.Mukherjee@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.